ПРОТЕОМНЫЕ ИССЛЕДОВАНИЯ В РЕВМАТОЛОГИИ

1. <div><p>Gygi S.P., Rochon Y., Franza B.R. et al. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19(3): 1720—30.</p><p>Anderson L., Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997; 18(3—4): 533—7.</p><p>Олейников А.В. Полупроводниковые флуоресцентные нанокристаллы (квантовые точки) в белковых биочипах (обзорная статья). Биоорг. химия 2011; 37(2): 171 —89.</p><p>Wasinger V.C., Cordwell S.J., Cerpa-Poljak A. et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995; 16(7): 1090—4.</p><p>Lambrecht S., Tilleman K., Elewaut D. et al. Proteomics in rheumatology: The beginning of a fairy tale? Proteomics Clin Appl 2008; 2(3): 411—9.</p><p>Glökler J., Angenendt P. Protein and antibody microarray technology. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 797(1—2): 229—40.</p><p>Vanarsa K., Mohan C. Proteomics in rheumatology: the dawn of a new era. F.1000 Med Rep 2010; 8(2): 87.</p><p>Говорун В.М., Иванов В.Т. Протеомика и пептидомика в фундаментальных и прикладных медицинских исследованиях. Биоорг. химия 2011; 37(2): 199—215.</p><p>Ye Y., Mar E.C., Tong S. et al. Application of proteomics methods for pathogen discovery. J Virol Methods 2010; 163(1): 87—95.</p><p>Лебедев А.Т. Масс-спектрометрия в органической химии. М.: БИНОМ, 2003; 10.</p><p>Matt P., Fu Z., Fu Q. et al. Biomarker discovery: proteome fractionation and separation in biological samples. Physiol Genomics 2008; 33(1): 12—7.</p><p>Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1(11): 845—67.</p><p>MacBeath G. Protein microarrays and proteomics. Nat Genet 2002; 32(Suppl): 526—32.</p><p>Stoll D., Templin M.F., Schrenk M. et al. Protein microarray technology. Front Biosci 2002; 1(7): 13—32.</p><p>Zhu H., Bilgin M., Bangham R. et al. Global analysis of protein activities using proteome chips. Science 2001; 293(5537): 2101—5.</p><p>Чечеткин Д.В., Прокопенко Д.В., Макаров А.А. и др. Биочипы для медицинской диагностики. Росс. нанотехнол. 2006; 1(1,2): 13—27.</p><p>Ройт А. Основы иммунологии. М.: Мир, 1991; 328.</p><p>Kader H.A., Tchernev V.T., Satyaraj E. et al. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. Am J Gastroenterol 2005; 100(2): 414—23.</p><p>Hall D.A., Ptacek J., Snyder M. Protein microarray technology. Mech Ageing Dev 2007; 128(1): 161 —7.</p><p>Chen C.S., Zhu H. Protein microarrays. Biotechniques 2006; 40(4): 423—7.</p><p>Finkel N.H., Lou X., Wang C. et al. Barcoding the microworld. Anal Chem 2004; 76(19): 352A—359A.</p><p>Braeckmans K., de Smedt S.C., Leblans M. et al. Encoding microcarriers: present and future technologies. Nat Rev Drug Discov 2002; 1(6): 447—56.</p><p>Fortina P., Kricka L.J., Surrey S. et al. Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol 2005; 23(4): 168—73.</p><p>Fan J.B., Chee M.S., Gunderson K.L. Highly parallel genomic assays. Nat Rev Genet 2006; 7(8): 632—44.</p><p>Ramachandran N., Raphael J.V., Hainsworth E. et al. Next-generation high-density self-assembling functional protein arrays. Nat Methods 2008; 5(6): 535—8.</p><p>Situma C., Hashimoto M., Soper S.A. Merging microfluidics with microarray-based bioassays. Biomol Eng 2006; 23(5): 213—31.</p><p>Meza M.B. Bead-based HTS applications in drug discovery. Drug Discovery Today 2000; 5(1): 38—41.</p><p>Nolan J.P., Sklar L.A. Suspension array technology: evolution of the flat-array paradigm. Trends Biotechnol 2002; 20(1): 9—12.</p><p>Fulton R.J., McDade R.L., Smith P.L. et al. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 1997; 43(9): 1749—56.</p><p>Battersby B.J., Bryant D., Meutermans W. et al. Toward larger chemicallibraries: encoding with fluorescent colloids in combinatorial chemistry. J Am Chem Soc 2000; 122: 2138—9.</p><p>Xu H., Sha M.Y., Wong E.Y. et al. Multiplexed SNP genotyping using the Qbead system: a quantum dot-encoded microsphere-based assay. Nucleic Acids Res 2003; 31(8): e43.</p><p>Han M., Gao X., Su J.Z. et al. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol 2001; 19(7): 631—5.</p><p>Zhao X.W., Liu Z.B., Yang H. et al. Uniformly colorized beads for multiplex immunoassay. Chem Mater 2006; 18(9): 2443—9.</p><p>Cunin F., Schmedake T.A., Link J.R. et al. Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater 2002; 1(1): 39—41.</p><p>Su X., Zhang J., Sun L. et al. Composite organic-inorganic nanoparticles (COINs) with chemically encoded optical signatures. Nano Lett 2005; 5(1): 49—54.</p><p>Fenniri H., Chun S., Ding L. et al. Preparation, physical properties, on-bead binding assay and spectroscopic reliability of 25 bar-coded polystyrene-poly(ethylene glycol) graft copolymers. J Am Chem Soc 2003; 125(35): 10546—60.</p><p>Zhi Z.L., Morita Y., Hasan Q. et al. Micromachining microcarrier-based biomolecular encoding for miniaturized and multiplexed immunoassay. Anal Chem 2003; 75(16): 4125—31.</p><p>Nicewarner-Pena S.R., Freeman R.G., Reiss B.D. et al. Submicrometer metallic barcodes. Science 2001; 294(5540): 137-41.</p><p>Sha M.Y., Walton I.D., Norton S.M. et al. Multiplexed SNP genotyping using nanobarcode particle technology. Anal Bioanal Chem 2006; 384(3): 658—66.</p><p>Evans M., Sewter C., Hill E. et al. An encoded particle array tool for multiplex bioassays. Assay Drug Dev Technol 2003; 1(1 Pt 2): 199-207.</p><p>Moran E.J., Sarshar S., Cargill J.F. et al. Radio frequency tag encoded combinatorial library method for the discovery of tripeptide-substituted cinnamic acid inhibitors of the protein tyrosine phosphatase PTP1B. J Am Chem Soc 1995; 117: 10787-8.</p><p>Nicolaou K.C., Xiao X.Y., Parandoosh Z. et al. Radiofrequency Encoded Combinatorial Chemistry. Angew Chem Int Ed 1995; 34: 2289-91.</p><p>McHugh T.M., Miner R.C., Logan L.H. et al. Simultaneous detection of antibodies to cytomegalovirus and herpes simplex virus by using flow cytometry and a microsphere-based fluorescence immunoassay. J Clin Microbiol 1988; 26(10): 1957—61.</p><p>Vaino A.R., Janda K.D. Euclidean shape-encoded combinatorial chemical libraries. Proc Natl Acad Sci USA 2000; 97(14): 7692-6.</p><p>Claudon A., Vergnaud P., Valverde C. et al. New automated multiplex assay for bone turnover markers in osteoporosis. Clin Chem 2008; 54(9): 1554-63.</p><p>Chandra P.E., Sokolove J., Hipp B.G. et al. Novel multiplex technology for diagnostic characterization of rheumatoid arthritis. Arthr Res Ther 2011; 24; 13(3): 102.</p><p>Haab B.B., Dunham M.J., Brown P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001; 2: 1-13.</p><p>Robinson W.H., DiGennaro C., Hueber W. et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002; 8: 295-301.</p><p>Fodor S.P., Read J.L., Pirrung M.C. et al. Lightdirected, spatially addressable parallel chemical synthesis. Science 1991; 251: 767-73.</p><p>Joos T.O., Schrenk M., Hopfl P. et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 2000; 21: 2641-50.</p><p>Büssow K., Cahill D., Nietfeld W. et al. A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. Nucleic Acids Res 1998; 26: 5007-8.</p><p>Lueking A., Horn M., Eickhoff H. et al. Protein microarrays for gene expression and antibody screening. Anal Biochem 1999; 270: 103-11.</p><p>He M., Taussig M.J. Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). Nucleic Acids Res 2001; 29: 73.</p><p>Ge H. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA, and protein-ligand interactions. Nucleic Acids Res 2000; 28: 3i.</p><p>Geysen H.M., Meloen R.H., Barteling S.J. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA 1984; 81: 3998-4002.</p><p>James J., Harley J. Linear epitope mapping of an Sm B/B_2 polypeptide. J Immunol 1992; 148: 2074-9.</p><p>Atkinson A.J., Colburn W.A., Degruttola V.G. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.</p><p>Zhang H., Liu A.Y., Loriaux P. et al. Mass spectrometric detection of tissue proteins in plasma. Mol Cell Proteomics 2007; 6: 64-71.</p><p>Etzioni R., Urban N., Ramsey S. et al. The case for early detection. Nat Rev Cancer 2003; 3: 243-52.</p><p>Rifai N., Gillette M.A., Carr S.A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006; 24: 971-83.</p><p>Guo Y., Fu Z., van Eyk J.E. A proteomic primer for the clinician. Proc Am Thorac Soc 2007; 4: 9-17.</p><p>Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol (Lond) 2005; 563: 23-60.</p><p>Issaq H.J., Xiao Z., Veenstra T.D. Serum and plasma proteomics. Chem Rev 2007; 107: 3601-20.</p><p>Ye X., Blonder J., Veenstra T. Briefings in functional genomics and proteomics. Brief Funct Genom 2009; 8(2): 126—35.</p><p>Zolotarjova N., Martosella J., Nicol G. et al. Differences among techniques for high-abundant protein depletion. Proteomics 2005; 5: 3304-13.</p><p>Tambor V., Fucikova A., Lenco J. et al. Application of proteomics in biomarker discovery: a primer for the clinician. Physiol Res 2010; 59: 471-97.</p><p>Wener M. Multiplex, megaplex, index, and complex: the present and future of laboratory diagnostics in rheumatology. Arthr Res Ther 2011; 13: 134.</p><p>Zhou X., Fragala M.S., McElhaney J. et al. Conceptual and methodological issues relevant to cytokine and infl ammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care 2010; 13(5): 541-7.</p><p>Bossuyt P.M. The thin line between hope and hype in biomarker research. JAMA 2011; 305: 2229-30.</p><p>Katz M.H. Multivariable analysis: a primer for readers of medical research. Ann Intern Med 2003; 138: 644-50.</p><p>Miossec P., Verweij C.L., Klareskog L. et al. Biomarkers and personalized medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies. Ann Rheum Dis 2011; 70(10): 1713-8.</p><p>Gibson D.S., Rooney M.E., Finnegan S. et al. Biomarkers in rheumatology, now and in the future. Rheumatology (Oxford) 2012; 51(3): 423—33.</p><p>Zhang X., Jin M., Wu H. et al. Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int 2008; 74: 799-807.</p><p>Wu T.F., Fu Y., Brekken D. et al. Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis. J Immunol 2010; 184: 2183-93.</p><p>Rovin B.H., Zhang X. Biomarkers for lupus nephritis: the quest continues. Clin J Am Soc Nephrol 2009; 4: 1858-65.</p><p>Hjelmervik T.O., Jonsson R., Bolstad A.I. The minor salivary glandproteome in Sjogren's syndrome. Oral Dis 2009; 15: 342-53.</p><p>Grau S., Richards P.J., Kerr B. et al. The role of human HtrA1 in arthritic disease. J Biol Chem 2006; 281: 6124-9.</p><p>Chamberland A., Wang E., Jones A.R. et al. Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo. J Biol Chem 2009; 284: 27352-9.</p><p>Tallheden T., Karlsson C., Brunner A. et al. Gene expression during redifferentiation of human articular chondrocytes. Osteoarthr Cartilage 2004; 12: 525-35.</p><p>Blain E.J., Gilbert S.J., Hayes A.J. et al. Disassembly of the vimentin cytoskeleton disrupts articular cartilage chondrocyte homeostasis. Matrix Biol 2006; 25: 398-408.</p><p>Naishiro Y., Suzuki C., Kimura M. et al. Plasma analysis of rheumatoid arthritis by SELDI. Nihon Rinsho Meneki Gakkai Kaishi 2007; 30: 145-50.</p><p>Zheng X., Wu S.L., Hincapie M. et al. Study of the human plasma proteome of rheumatoid arthritis. J Chromatogr A 2009; 1216: 3538-45.</p><p>Jin E.H., Shim S.C., Kim H.G. et al. Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders. Exp Mol Med 2009; 41: 354-61.</p><p>Mallya R.K., Vergani D., Tee D.E. et al. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease-activity. Clin Exp Immunol 1982; 48: 747—53.</p><p>Chang X., Cui Y., Zong M. et al. Identification of proteins with increased expression in rheumatoid arthritis synovial tissues. J Rheumatol 2009; 36: 872—80.</p><p>Trocme C., Marotte H., Baillet A. et al. Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis. Ann Rheum Dis 2009; 68: 1328—33.</p><p>Doherty N.S., Littman B.H., Reilly K. et al. Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis. Electrophoresis 1998; 19(2): 355—63.</p><p>Scott L.J., Evans E.L., Dawes P.T. et al. Comparison of IgA-alpha1-antitrypsin levels in rheumatoid arthritis and seronegative oligoarthritis: complex formation is not associated with inflammation per se. Br J Rheumatol 1998; 37: 398—404.</p><p>Tilleman K., van Beneden K., Dhondt A. et al. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry. Proteomics 2005; 5: 2247—57.</p><p>Sinz A., Bantscheff M., Mikkat S. et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 2002; 23: 3445—56.</p><p>Drynda S., Ringel B., Kekow M. et al. Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol Res Pract 2004; 200: 165—71.</p><p>Raza K., Falciani F., Curnow S.J. et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthr Res Ther 2005; 7: R784— R795.</p><p>Hueber W., Tomooka B.H., Zhao X. et al. Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann Rheum Dis 2007; 66: 712—9.</p><p>Syversen S.W., Goll G.L., Haavardsholm E.A. et al. A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients. Arthr Res Ther 2008; 10: R28.</p><p>Jager W., Hoppireijs E.P.A.H., Wulffraat N.M. et al. Blood and synovial fluid cytokines signatures in patients with juvenile idiopatic arthritis a cross-sectional study. Ann Rheum Dis 2007; 66: 589—98.</p><p>Cavet G., Centola M., Shen Y. et al. Development of a multibiomarker test for rheumatoid arthritis (RA) disease activity. Ann Rheum Dis 2010; 69(Suppl 3): 148.</p><p>Liao H., Wu J., Kuhn E. et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthr Rheum 2004; 50: 3792—803.</p><p>Katano M., Okamoto K., Arito M. et al. Implication of granulocytemacrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthr Res Ther 2009,11: R3.</p><p>Bo G.P., Zhou L.N., He W.F. et al. Analyses of differential proteome of human synovial fibroblasts obtained from arthritis. Clin Rheumatol 2009; 28(2): 191—9.</p><p>Scott L.J., Evans E.L., Dawes P.T. et al. Two-dimensional electrophoretic analysis of disease-associated proteins in human cerebrospinal fluid from patients with rheumatoid arthritis. J Electrophoresis 2005; 49: 23—7</p><p>Wu J., Liu W., Bemis A. et al. Comparative proteomic characterization of articular cartilage tissue from normal donors and patients with osteoarthritis. Arthr Rheum 2007; 56: 3675—84.</p><p>Guo D., Tan W., Wang F. et al. Proteomic analysis of human articular cartilage: identification of differentially expressed proteins in knee osteoarthritis. Joint Bone Spine 2008; 75: 439—44.</p><p>Ruiz-Romero C., Calamia V., Mateos J. et al. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dis-mutase points to a redox imbalance. Mol Cell Proteomics 2009; 8: 172—89.</p><p>Lambrecht S., Verbruggen G., Verdonk P.C. et al. Differential proteome analysis of normal and osteoarthritic chondrocytes reveals distortion of vimentin network in osteoarthritis. Osteoarthr Cartilage 2008; 16: 163—73.</p><p>Liu J., Zhu P., Peng J. et al. Identification of diseaseassociated proteins by proteomic approach in ankylosing spondylitis. Biochem Biophys Res Commun 2007; 357: 531—6.</p><p>Wright C., Edelmann M., di Gleria K. et al. Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway. Ann Rheum Dis 2009; 68: 1626—32.</p><p>Giusti L., Baldini C., Bazzichi L. et al. Proteome analysis of whole saliva: a new tool for heumatic diseases-the example of Sjogren's syndrome. Proteomics 2007; 7: 1634—43.</p><p>Fleissig Y., Deutsch O., Reichenberg E. et al. Different proteomic protein patterns in saliva of Sjogren's syndrome patients. Oral Dis 2009; 15: 61—8.</p><p>Peluso G., De Santis M., Inzitari R. et al. Proteomic study of salivary peptides and proteins in patients with Sjogren's syndrome before and after pilocarpine treatment. Arthr Rheum 2007; 56: 2216—22.</p></div><br />